Evidence map›Paper›PMID 38524156›Full record

ArticleHardwareX2024

BioCloneBot: A versatile, low-cost, and open-source automated liquid handler.

Ke'Koa Cdh Wells, Nawwaf Kharma, Brandon B Jaunky, Kaiyu Nie, Gabriel Aguiar-Tawil, Daniel Berry

Abstract read
In one paragraph

Article in HardwareX, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ke'Koa Cdh WellsDepartment of Electrical and Computer Engineering, Concordia University, Montréal, Québec, Canada.
Nawwaf KharmaDepartment of Electrical and Computer Engineering, Concordia University, Montréal, Québec, Canada.
Brandon B JaunkyDepartment of Biology, Concordia University, Montréal, Québec, Canada.
Kaiyu NieDepartment of Electrical and Computer Engineering, Concordia University, Montréal, Québec, Canada.
Gabriel Aguiar-TawilDepartment of Biology, Concordia University, Montréal, Québec, Canada.
Daniel BerryDepartment of Mechanical, Industrial and Aerospace Engineering, Concordia University, Montréal, Québec, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liquid handler systems can provide significant benefits to researchers by automating laboratory work, however, their unaffordable price provides a steep barrier to entry. Therefore, we provide the BioCloneBot, a versatile, low-cost, and open-source automated liquid handler. This system can be easily built with 3D-printed parts and readily available commercial components. The BioCloneBot is highly adaptive to user needs and facilitates various liquid handling tasks in research and diagnostics. Its user-friendly interface and programmable nature make it suitable for a wide range of applications, from small-scale experiments to larger laboratory setups. By utilizing BioCloneBot, researchers and scientists can streamline their liquid handling processes without the financial constraints posed by traditional systems. In this paper, we detail the design, construction, and validation of BioCloneBot, showcasing its precise control, accuracy, and repeatability in various liquid handling tasks. The open-source nature of the system encourages collaboration and customization, enabling researchers to contribute and adapt the technology to specific experimental requirements.

Indexed as

3D printingDNA cloningLiquid handlerOpen-sourceSynthetic biology

Identifiers

PMID38524156
PMCPMC10955647

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.